← Open Payments lookup

MAGEGAN SAKHIZADA: Open Payments

NPI 1992370738 · STOCKTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$437 in 24 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $390 · 2025 $437

Food & beverage: $437
CompanyPaymentsAmount
Sage Therapeutics, LLC8$135
MAYNE PHARMA COMMERCIAL LLC7$121
Supernus Pharmaceuticals, Inc.4$84
Astellas Pharma US Inc2$33
Sumitomo Pharma America, Inc.1$26
Bayer Healthcare Pharmaceuticals Inc.1$20
VERTEX PHARMACEUTICALS INCORPORATED1$17

Products named: ZURZUVAE, Qelbree, Veozah, MYFEMBREE, Mirena, JOURNAVX.

Industry payments across CA — which companies pay providers there.